Sanofi chairman lambastes generic drug makers

Jean-Francois Dehecq, chairman of Sanofi-Aventis, tells the Financial Times that he is "scandalized" by generic drug makers in developing countries who make cheap knock-offs in their countries and then sell them at a discount to patients in affluent countries. Dehecq says the companies are simply exploiting their countries' cheap labor and not making cheaper drugs available to their own populations.

- here's the report on Dehecq's remarks from The Financial Times (sub. req.)

Suggested Articles

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.